Protein-energy malnutrition in chronic kidney disease

Зуева, Т. В.; Уразлина, С. Е.; Жданова, Т. В.

doi:10.29296/25877305-2021-01-06

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…GM correction in CKD should be carried out to reduce the production of uremic and intestinal toxins and prevent metabolic (insulin resistance, vascular calcification) and other disorders. [ 60 ] A low-protein diet, adsorbents, prebiotics, and probiotics can be used to correct GM. In case of successful correction, the intestinal wall permeability improves, the synthesis of intestinal toxins reduces, and the microflora in the large intestine normalizes.…”

Section: Gm Correction In Ckdmentioning

confidence: 99%

Gut microbiota and the ways to correct it in chronic kidney disease

Sturov,

Popov,

Belikov

2023

Indian J Nephrol

View full text Add to dashboard Cite

Approximately 13% of the Russian population suffers from chronic kidney disease (CKD). Such a high prevalence of the disease, as well as the complexity and high cost of renal replacement therapy, explain the need for developing and implementing new approaches to treat patients at the pre-dialysis stages. The data collected in recent decades highlight the importance of gut microbiota in the progression of CKD. This review provides information about the microbiota composition in healthy individuals and patients with CKD and discusses the mechanisms of interaction in the intestine–kidney system. The article also presents the specifics of the violation of gut microbiota (GM) and correction thereof in CKD.

show abstract

Section: Gm Correction In Ckdmentioning

confidence: 99%

Gut microbiota and the ways to correct it in chronic kidney disease

Sturov,

Popov,

Belikov

2023

Indian J Nephrol

View full text Add to dashboard Cite

show abstract

Modern Drugs for Nutritional Support of the Patient

Morozov,

Sergeev,

Askerov

et al. 2024

Farmaciya

View full text Add to dashboard Cite

Introduction. Nowadays, nutritional support is an integral part of the management of patients in hospitals of any profile. Parenteral nutrition (PN) is a vital therapy and is indicated in those situations when enteral or oral nutrition is impossible or insufficient, for example, in such clinical conditions as advanced variants of Crohn's disease and ulcerative colitis, stenotic deformities of the esophagus, comatose change of consciousness, cancer cachexia, neuropathies of various etiologies, and others. The aim of the present study was to investigate preparations for parenteral nutrition as part of an integrated approach to the treatment of various pathologic conditions. Parenteral nutrition is in modern clinical medicine an integral part of adequate treatment in the presence of protein-energy deficiency in patients. Currently, there are many nutrient mixtures that can compensate for nutrient losses in various pathologies. There are standard systems that can compensate for substrate deficiencies individually, but the most effective are considered to be 3-in-1 systems, which are more harmonious and balanced in their composition, which, in turn, leads to the fullest satisfaction of the nutrient needs of patients. Conclusion. At the same time, it is necessary to take into account that in case of irrational use, the risks for the patient increase, therefore, in order to mitigate them, it is necessary to implement programs to control the production of mixtures and assess their qualitative and quantitative composition.

show abstract

Protein-energy malnutrition in chronic kidney disease

Cited by 2 publications

References 0 publications

Gut microbiota and the ways to correct it in chronic kidney disease

Gut microbiota and the ways to correct it in chronic kidney disease

Modern Drugs for Nutritional Support of the Patient

Contact Info

Product

Resources

About